Inversago Pharma is a Canadian biotechnology company developing peripherally restricted CB1 receptor antagonists/inverse agonists for metabolic, fibrotic, and related diseases.…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Inversago Pharma →Already a subscriber? Sign in
Xcout Intel tracks Inversago Pharma continuously — this profile deepens as new filings, funding, people and hiring data arrive.